Add BrightSurf on Google Email

What the age of your brain says about you

Using neuroimaging techniques and multivariate statistical models, researchers found that people with older-than-chronological-age brains are more likely to experience deteriorating conditions and early death. Combining brain-predicted age with DNA-related epigenetic biomarkers improves mortality predictions.

SourceSpringer·JournalMolecular Psychiatry·DateApr 25, 2017

Elsevier announces the launch of Personalized Medicine in Psychiatry

Personalized Medicine in Psychiatry aims to increase treatment efficacy and reduce adverse effects by considering individual patient characteristics. The journal will publish research on endophenotypes, pharmacologic approaches, and education, with the goal of identifying predictors of response and tailoring treatments.

SourceElsevier·JournalPersonalized Medicine in Psychiatry·DateApr 24, 2017

Predicting -- and preventing -- psychiatric morbidity after ARDS

A new study by Michigan Medicine researchers identified that younger age, female gender, higher severity of illness, fewer days of corticosteroid treatments, and treatment with GM-CSF were associated with more severe psychiatric symptoms. The study found that more days of corticosteroid treatments seemed to be protective from anxiety, ...

SourceMichigan Medicine - University of Michigan·JournalAnnals of the American Thoracic Society·DateApr 5, 2017

Self-harm linked to violence towards others

A Swedish registry study found that individuals who self-harm are at a five-fold risk of being convicted for a violent crime compared to those who have never received clinical care. Self-harm behaviour and violent criminality may be manifestations of a common underlying vulnerability.

SourceKarolinska Institutet·JournalJAMA Psychiatry·DateApr 5, 2017

A new blue gene: NKPD1 variant increases depression risk

A recent study published in Biological Psychiatry has identified a link between rare variants of the NKPD1 gene and depressive symptoms. Researchers found that nearly 2,000 people with depressive symptoms were analyzed, revealing a possible genetic connection to depression.

SourceElsevier·JournalBiological Psychiatry·DateApr 4, 2017

The Hierarchical Taxonomy of Psychopathology (HiTOP): A new model that addresses limitations of traditional taxonomies

The Hierarchical Taxonomy of Psychopathology (HiTOP) proposes viewing mental health as a spectrum, rather than categorizing it. This system simplifies diagnosis by recognizing that most patients have co-occurring disorders and classifying psychopathology at multiple levels of hierarchy.

SourceAmerican Psychological Association·JournalJournal of Abnormal Psychology·DateMar 24, 2017

Treating cocaine addiction by reducing our appetite for drugs?

A new study in Biological Psychiatry suggests that blocking hypocretin signaling may provide a new avenue for treating cocaine addiction. The study found that blocking hypocretin signaling reduced cocaine intake in rats allowed long access to cocaine, and restored the normal GABAergic system.

SourceElsevier·JournalBiological Psychiatry·DateMar 16, 2017

Major research project provides new clues to schizophrenia

Researchers at Karolinska Institutet have discovered that patients with schizophrenia have lower levels of the neurotransmitter GABA and altered immune cell function. These findings provide new clues to the disease mechanisms of schizophrenia, but follow-up studies are needed to determine if these changes are causes or effects.

SourceKarolinska Institutet·JournalMolecular Psychiatry·DateMar 14, 2017

The Lancet Psychiatry: Experts ask: Can cannabis be made safer?

The Lancet Psychiatry experts argue that cannabis use can be made safer through various strategies, including regulating potency, reducing tobacco use, and exploring the effects of CBD modification. The authors also highlight the need for more research on the harms posed by different levels of THC and CBD content.

SourceThe Lancet·JournalThe Lancet Psychiatry·DateMar 1, 2017

Psychiatric illness may increase stroke risk

Research found that patients with depression, anxiety, PTSD, or other psychiatric disorders have an increased risk of stroke, especially in the immediate post-diagnosis period. The study's lead researcher suggests that psychological distress may contribute to increased blood pressure and inflammation, leading to a higher stroke risk.

Sick and tired -- not just a figure of speech

A large-scale study found that genetics accounts for about eight percent of people's differences in self-reported tiredness/low energy. Most of these genetic contributions overlapped with mental and physical health conditions, as well as lifestyle factors like smoking and weight.

SourceSpringer·JournalMolecular Psychiatry·DateFeb 14, 2017

More screen time for kids isn't all that bad

A study found that moderate to high levels of screen time are not associated with negative outcomes in teenagers. The researcher suggests that parents should focus on how media is used rather than just time consumption, as it can foster learning and socialization.

SourceSpringer·JournalPsychiatric Quarterly·DateFeb 7, 2017

Depressed patients with earlier and more severe symptoms have high genetic risk for major psychiatri

A recent study found that depressed patients with an early age at onset and higher symptom severity have a significantly increased genetic risk for major depressive disorder, bipolar disorder, and schizophrenia. The research used genome-wide data to identify specific subgroups of depressed patients based on their clinical characteristics.

SourceElsevier·JournalBiological Psychiatry·DateFeb 7, 2017

Prenatal infection may alter brain development via epigenetic changes

A new study published in Biological Psychiatry found that prenatal infection can cause long-term alterations in the programming of the offspring's genome through epigenetic modifications, leading to behavioral abnormalities. The findings suggest that earlier infection may lead to more serious effects on neurodevelopment.

SourceElsevier·JournalBiological Psychiatry·DateJan 24, 2017

Mouse model points to potential new treatment for Alzheimer's disease

Researchers have discovered a potential new treatment for Alzheimer's disease by inhibiting the 12/15-lipoxygenase enzyme, which is elevated in patients with the condition. The study found that this inhibitor reverses cognitive decline and neuropathology in an AD mouse model, even after symptoms have already developed.

SourceElsevier·JournalBiological Psychiatry·DateJan 5, 2017

Maternal depression across the first years of life impacts children's neural basis of empathy

A study found that maternal depression in early childhood increases children's susceptibility to psychopathology and social-emotional problems. Mother-child interaction patterns also play a crucial role in this effect. Improving mother-child interactions may help reduce the effects of maternal depression on children's development.

SourceElsevier·JournalJournal of the American Academy of Child & Adolescent Psychiatry·DateJan 3, 2017

Single dose of hallucinogenic drug psilocybin relieves anxiety and depression in patients with advanced cancer

A clinical trial led by NYU Langone Health found that psilocybin significantly reduces mental anguish in distressed cancer patients for months. The study showed that one-time treatment with psilocybin quickly brought relief from distress that then lasted for over six months in 80% of the participants.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalJournal of Psychopharmacology·DateDec 1, 2016

How did web-based cognitive therapy work for insomnia?

A randomized clinical trial found that web-based cognitive behavior therapy for insomnia (CBT-I) improved sleep outcomes in adults. The fully automated and interactive SHUTi intervention was more effective than access to a patient education website alone, with participants showing significant improvements in sleep duration and quality.

SourceJAMA Network·JournalJAMA Psychiatry·DateNov 30, 2016